PsyPost
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Neuroscience
  • About
No Result
View All Result
Join
My Account
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology

A single dose of 5-MeO-DMT produces rapid and persistent improvements in life satisfaction and psychopathological symptoms

by Eric W. Dolan
September 18, 2019
Reading Time: 3 mins read
(Photo credit: BurningMax)

(Photo credit: BurningMax)

Share on TwitterShare on Facebook

A single inhalation of the psychedelic drug 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is associated with sustained improvements in satisfaction with life, mindfulness, and a reduction of psychopathological symptoms, according to preliminary research published in Psychopharmacology.

“5-MeO-DMT is a lesser known psychedelic compared to, for example, ayahuasca and psilocybin — and thus very limited research exists,” explained study author Malin Uthaug (@malin.uthaug), a PhD candidate at Maastricht University in the Netherlands.

5-MeO-DMT occurs naturally in the venom of some toads and in a variety of plants species. It can also be produced synthetically.

“Essentially, I saw this as a niche area, and brought it upon myself to investigate its effect and therapeutic potential further as part of my doctorate work at Maastricht University. This specific article summarizes the first study I did on the topic, but there are more to come,” Uthaug said.

In the study, 42 participants completed a battery of psychology tests before inhaling vapor from dried toad secretion containing 5-MeO-DMT. The participants completed the tests again about 24 hours later and 24 participants completed the tests yet again at a 4-week follow-up assessment.

“This study was a so-called ‘naturalistic observational study.’ This means that as a researcher, I simply observed what was occurring at sessions where toad secretion containing 5-MeO-DMT was administered to participants by facilitators, and distributed questionnaires to the participants,” Uthaug explained.

“Although there are limitations with this design (no placebo-control, participant bias, etc), it has an advantage in the sense that it allows researchers to get a better look at drug effects than what the current legality status of psychedelics permit.”

The researchers found that subjective ratings of life satisfaction, depression, anxiety, and mindfulness improved on the day after the session, and this effect persisted for four weeks. The findings are in line with a previous survey of 362 adults, which found that approximately 80& of respondents reported improvements in anxiety and depression after using 5-MeO-DMT.

Google News Preferences Add PsyPost to your preferred sources

But there also does not appear to be anything particularly special about toad venom compared to synthetic 5-MeO-DMT.

“Another important take-away from the study is that 5-MeO-DMT is the main compound in the toad secretion as demonstrated by our lab-analysis,” Uthaug said.

“This finding, as well as the outlined ethical and ecological consideration of toad secretion use, make a clear and strong argument for the discontinuation of toad secretion as a means of obtaining and consuming 5-MeO-DMT. In other words, ‘save a toad – exploit a chemist.‘”

Previous research has indicated that 5-MeO-DMT has a relatively safe profile of use and is predominantly used for spiritual exploration. But there is still much to learn about the psychedelic drug.

“The results of the present study are in no way conclusive, and more research is warranted to investigate 5-MeO-DMT further. The rest of our studies on 5-MeO-DMT (from my dissertation as well as other collaborations) are yet to be published, and include one study outlining the effects of 5-MeO-DMT on biomarkers (salivary cortisol and IL-6), and another comparing the effects and experiences following vaporization or intramuscular injection,” Uthaug told PsyPost.

“These will all amplify the current literature, but future clinical research and safety assessment of 5-MeO-DMT, specifically through the intramuscular route, is highly warranted before a clinical trial can commence.”

Uthaug also noted that some facilitators of 5-MeO-DMT face serious allegations of malpractice.

“Additionally, none of the facilitators have the necessary expertise (clinical background) to properly hold a safe space where altered states of consciousness can be entered, nor to screen for contraindications in participants that are included in a session,” she said. “This is dangerous as it puts people at unnecessary risk for having an unpleasant and even traumatic experience, which can impact them as well as those around them negatively.”

The study, “A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms“, was authored by M. V. Uthaug, R. Lancelotta, K. van Oorsouw, K. P. C. Kuypers, N. Mason, J. RakA. Šuláková, R. Jurok, M. Maryška, M. Kuchař, T. Páleníček, J. Riba, and J. G. Ramaekers.

RELATED

Psychedelic mushroom extract may offer enhanced brain benefits over synthetic psilocybin
Psilocybin

Estrogen levels may dictate how the brain reacts to psychedelics, new animal study indicates

May 14, 2026
Little-known psychedelic drug reduces motivation to take heroin in rats, study finds
Psychedelic Drugs

Are the benefits of psychedelics exaggerated? A new study highlights the problem of selection bias

May 12, 2026
Psychedelic therapy ignited a harrowing mental health crisis for one patient — but she would do it again
Psychedelic Drugs

New study explores the link between mystical psychedelic trips and a reduced fear of dying

May 11, 2026
Childhood ADHD traits linked to midlife distress, with societal exclusion playing a major role
Psychedelic Drugs

Real world outcomes support the benefits of psychedelic therapy for severe depression

May 9, 2026
Study finds microdosing LSD is not effective in reducing ADHD symptoms
Depression

LSD microdosing linked to acute mood improvements in adults with depression

May 8, 2026
Novel psychedelic compound 25C-NBF shows rapid antidepressant effects without addictive traits
Psychedelic Drugs

Novel psychedelic compound 25C-NBF shows rapid antidepressant effects without addictive traits

May 6, 2026
Psychedelic science breakthrough: Increased brain entropy from psilocybin predicts lasting psychological insight and well-being
Neuroimaging

Psychedelic science breakthrough: Increased brain entropy from psilocybin predicts lasting psychological insight and well-being

May 5, 2026
People with cannabis use disorder are more likely to be depressed, study finds
Cannabis

People with cannabis use disorder are more likely to be depressed, study finds

May 5, 2026

Follow PsyPost

The latest research, however you prefer to read it.

Daily newsletter

One email a day. The newest research, nothing else.

Google News

Get PsyPost stories in your Google News feed.

Add PsyPost to Google News
RSS feed

Use your favorite reader. We also syndicate to Apple News.

Copy RSS URL
Social media
Support independent science journalism

Ad-free reading, full archives, and weekly deep dives for members.

Become a member

Trending

  • The human brain processes the passage of time across three distinct stages
  • Brain scans identify the neural network that traps anxious people in cycles of self-blame
  • New study finds sustainable living relies on stable personality traits, not temporary bursts of willpower
  • Brooding identified as a major driver of bedtime procrastination, alongside physical markers of stress
  • Scientists challenge The Body Keeps the Score with a new predictive model of trauma

Science of Money

  • What 120 studies reveal about financial literacy as a lever for economic inclusion
  • When illness leads to illegality: How a cancer diagnosis reshapes the decision to commit a crime
  • The Goldilocks zone of sales pressure: Why a little urgency helps and too much hurts
  • What women really want from “girl power” ads: Six ingredients that make femvertising work
  • The seductive allure of neuroscience: Why brain talk feels so satisfying, even when it explains nothing

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Mental Health
  • Neuroimaging
  • Personality Psychology
  • Social Psychology
  • Artificial Intelligence
  • Cognitive Science
  • Psychopharmacology
  • Contact us
  • Disclaimer
  • Privacy policy
  • Terms and conditions
  • Do not sell my personal information

(c) PsyPost Media Inc

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy

(c) PsyPost Media Inc